Questcor faced two different blog attacks in 2012. In January, The Street Sweeper questioned the efficacy of Acthar and the promotional practices used by Questcor. Shares sank by as much as 18% over several weeks as the controversy swirled.
Many investors love when companies buy back shares or pay dividends. Questcor did both in 2012. The company doubled its share buyback program and initiated a dividend with a current forward yield of nearly 3%.
Fool contributor Keith Speights has no positions in the stocks mentioned above. The Motley Fool owns shares of Bio-Reference Laboratories. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.